Intrinsic Value of S&P & Nasdaq Contact Us

Surrozen, Inc. SRZN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$40.00
+28.7%

Surrozen, Inc. (SRZN) has a consensus analyst rating of Buy, based on 6 analysts covering the stock. Of those, 4 recommend buying, 0 recommend holding, and 2 recommend selling.

The analyst consensus price target for SRZN is $40.00, representing a +28.7% upside from the current price of $31.07. Price targets range from a low of $40.00 to a high of $40.00.

Analyst Consensus — SRZN

Buy
Strong Buy
0
Buy
4
Hold
0
Sell
2
Strong Sell
0
6 analysts
Price Targets
Consensus$40.00
High$40.00
Low$40.00
Median$40.00
Last Month Avg-
Last Quarter Avg$40.00
Last Year Avg$40.00
All-Time Count3
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message